Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 4
2020 4
2021 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.
Mansor R, Holly J, Barker R, Biernacka K, Zielinska H, Koupparis A, Rowe E, Oxley J, Sewell A, Martin RM, Lane A, Hackshaw-McGeagh L, Perks C. Mansor R, et al. Among authors: biernacka k. Oncotarget. 2023 Jan 26;14:44-46. doi: 10.18632/oncotarget.28344. Oncotarget. 2023. PMID: 36702334 Free PMC article. No abstract available.
Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study.
Tan VY, Bull CJ, Biernacka KM, Teumer A, Richardson TG, Sanderson E, Corbin LJ, Dudding T, Qi Q, Kaplan RC, Rotter JI, Friedrich N, Völker U, Mayerle J, Perks CM, Holly JMP, Timpson NJ. Tan VY, et al. Among authors: biernacka km. Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2207-2216. doi: 10.1158/1055-9965.EPI-21-0315. Epub 2021 Sep 28. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34583967 Free PMC article.
IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.
Mansor R, Holly J, Barker R, Biernacka K, Zielinska H, Koupparis A, Rowe E, Oxley J, Sewell A, Martin RM, Lane A, Hackshaw-McGeagh L, Perks C. Mansor R, et al. Among authors: biernacka k. Oncotarget. 2020 Jun 30;11(26):2543-2559. doi: 10.18632/oncotarget.27650. eCollection 2020 Jun 30. Oncotarget. 2020. PMID: 32655839 Free PMC article.
Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer.
Hackshaw-McGeagh LE, Penfold C, Shingler E, Robles LA, Perks CM, Holly JMP, Rowe E, Koupparis A, Bahl A, Persad R, Shiridzinomwa C, Johnson L, Biernacka KM, Frankow A, Woodside JV, Gilchrist S, Oxley J, Abrams P, Lane JA, Martin RM. Hackshaw-McGeagh LE, et al. Among authors: biernacka km. BMJ Open. 2019 Nov 6;9(11):e029480. doi: 10.1136/bmjopen-2019-029480. BMJ Open. 2019. PMID: 31699723 Free PMC article. Clinical Trial.
17 results